| Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study AR Rastinehad, H Anastos, E Wajswol, JS Winoker, JP Sfakianos, ... Proceedings of the National Academy of Sciences 116 (37), 18590-18596, 2019 | 781 | 2019 |
| Avoiding unnecessary magnetic resonance imaging (MRI) and biopsies: negative and positive predictive value of MRI according to prostate-specific antigen density, 4Kscore and … UG Falagario, A Martini, E Wajswol, PJ Treacy, P Ratnani, I Jambor, ... European urology oncology 3 (5), 700-704, 2020 | 101 | 2020 |
| Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers JP Sfakianos, J Daza, Y Hu, H Anastos, G Bryant, R Bareja, KK Badani, ... Nature communications 11 (1), 2540, 2020 | 48 | 2020 |
| Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: A report from the National Cancer Database K Attalla, DJ Paulucci, K Blum, H Anastos, KA Moses, KK Badani, ... Urologic Oncology: Seminars and Original Investigations 36 (1), 14. e17-14. e24, 2018 | 36 | 2018 |
| A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion‐guided biopsy: assessing the impact of inter‐reader variability on … E Wajswol, JS Winoker, H Anastos, U Falagario, K Okhawere, A Martini, ... BJU international 125 (4), 531-540, 2020 | 32 | 2020 |
| Predicting Complications Following Robot-Assisted Partial Nephrectomy with the ACS NSQIP® Universal Surgical Risk Calculator JS Winoker, DJ Paulucci, H Anastos, N Waingankar, R Abaza, DD Eun, ... The Journal of Urology 198 (4), 803-809, 2017 | 25 | 2017 |
| Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer F Audenet, AM Farkas, H Anastos, MD Galsky, N Bhardwaj, JP Sfakianos World journal of urology 36, 1741-1748, 2018 | 23 | 2018 |
| Clinicopathological and survival analysis of clinically advanced papillary and chromophobe renal cell carcinoma A Kaldany, DJ Paulucci, M Kannappan, AT Beksac, H Anastos, ... Urologic Oncology: Seminars and Original Investigations 37 (10), 727-734, 2019 | 16 | 2019 |
| Tim-3 and TIGIT mark Natural Killer cells susceptible to effector dysfunction in human bladder cancer AM Farkas, F Audenet, H Anastos, M Galsky, J Sfakianos, N Bhardwaj The Journal of Immunology 200 (1_Supplement), 124.14-124.14, 2018 | 15 | 2018 |
| TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer K Attalla, AM Farkas, H Anastos, F Audenet, MD Galsky, N Bhardwaj, ... Urologic Oncology: Seminars and Original Investigations 40 (9), 403-406, 2022 | 14 | 2022 |
| Cell death under epithelial–mesenchymal transition control in prostate cancer therapeutic response D Begemann, H Anastos, N Kyprianou International Journal of Urology 25 (4), 318-326, 2018 | 13 | 2018 |
| Black race may be associated with worse overall survival in renal cell carcinoma patients H Anastos, A Martini, N Waingankar, DJ Paulucci, AT Beksac, J Daza, ... Urologic Oncology: Seminars and Original Investigations 38 (12), 938. e9-938 …, 2020 | 9 | 2020 |
| Displacement of lower pole stones during retrograde intrarenal surgery improves stone-free status: a prospective randomized controlled trial AJ Yaghoubian, H Anastos, JA Khusid, R Shimonov, DJ Lundon, R Khargi, ... The Journal of Urology 209 (5), 963-970, 2023 | 8 | 2023 |
| Targeted ablative therapies for prostate cancer JS Winoker, H Anastos, AR Rastinehad Genitourinary Cancers, 15-53, 2018 | 6 | 2018 |
| Reverse trendelenburg positioning minimizes stone retropulsion during ureteroscopic laser lithotripsy: a prospective randomized study H Anastos, AJ Yaghoubian, JA Khusid, RA Chandhoke, DJ Lundon, ... Journal of Endourology 37 (6), 660-666, 2023 | 4 | 2023 |
| Tim-3 and TIGIT mark NK and T cells susceptible to effector dysfunction in human bladder cancer AM Farkas, F Audenet, H Anastos, WK Oh, MD Galsky, JP Sfakianos, ... Cancer Research 78 (13_Supplement), 4745-4745, 2018 | 2 | 2018 |
| Sientific program of 36th World Congress of endourology Programm Book M Takhar, M Alshalalfa, A Gupta, S Prasad J. Endourol 32, P1-A573, 2018 | 2 | 2018 |
| GOLD NANO-PARTICLE DIRECTED FOCAL LASER ABLATION FOR PROSTATE TUMORS USING US AND MR FUSION TECHNOLOGY: V4-02 JS Winoker, PA Shukla, MA Carrick, H Anastos, CJ Knauer, AK Tewari, ... Journal of Urology 197 (4), e375-e376, 2017 | 2 | 2017 |
| PD26-08 IMPACT OF REVERSE TRENDELENBURG POSITION ON URETERAL STONE RETROPULSION: A PROSPECTIVE RANDOMIZED STUDY J Khusid, H Anastos, R Chandhoke, D Lundon, A Sadiq, J Bamberger, ... Journal of Urology 206 (Supplement 3), e440, 2021 | 1 | 2021 |
| MP20-16 MR/US FUSION GUIDED ULTRA-FOCAL GOLD NANOSHELL DIRECTED LASER ABLATION OF PROSTATE TUMORS: SIDE EFFECTS AND 1-YEAR FUNCTIONAL OUTCOMES: PHASE I/II CLINICAL TRIAL E Wajswol, H Anastos, J Winoker, A Martini, J Sfakianos, C Knauer, ... Journal of Urology 201, e289-e290, 2019 | 1 | 2019 |
